• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BET 溴结构域抑制通过诱导 Bim 触发 NF1 相关恶性外周神经鞘瘤的细胞凋亡。

BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.

机构信息

Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA; Cancer Biology Graduate Program, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.

Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9133, USA.

出版信息

Cell Rep. 2014 Jan 16;6(1):81-92. doi: 10.1016/j.celrep.2013.12.001. Epub 2013 Dec 27.

DOI:10.1016/j.celrep.2013.12.001
PMID:24373973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3904298/
Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive sarcomas that develop sporadically or in neurofibromatosis type 1 (NF1) patients. There is no effective treatment for MPNSTs and they are typically fatal. To gain insights into MPNST pathogenesis, we utilized an MPNST mouse model that allowed us to study the evolution of these tumors at the transcriptome level. Strikingly, in MPNSTs we found upregulation of a chromatin regulator, Brd4, and show that BRD4 inhibition profoundly suppresses both growth and tumorigenesis. Our findings reveal roles for BET bromodomains in MPNST development and report a mechanism by which bromodomain inhibition induces apoptosis through induction of proapoptotic Bim, which may represent a paradigm shift in therapy for MPNST patients. Moreover, these findings indicate epigenetic mechanisms underlying the balance of anti- and proapoptotic molecules and that bromodomain inhibition can shift this balance in favor of cancer cell apoptosis.

摘要

恶性外周神经鞘瘤(MPNST)是一种高度侵袭性肉瘤,可散发性发生或出现在神经纤维瘤病 1 型(NF1)患者中。目前尚无针对 MPNST 的有效治疗方法,此类肿瘤通常是致命的。为了深入了解 MPNST 的发病机制,我们利用 MPNST 小鼠模型,能够在转录组水平上研究这些肿瘤的演变。引人注目的是,我们在 MPNST 中发现了染色质调节剂 Brd4 的上调,并表明 BRD4 抑制可显著抑制生长和肿瘤发生。我们的研究结果揭示了 BET 溴结构域在 MPNST 发展中的作用,并报告了溴结构域抑制通过诱导促凋亡 Bim 诱导细胞凋亡的机制,这可能代表了 MPNST 患者治疗的范式转变。此外,这些发现表明了调控抗凋亡和促凋亡分子平衡的表观遗传机制,并且溴结构域抑制可以使这种平衡有利于癌细胞凋亡。

相似文献

1
BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.BET 溴结构域抑制通过诱导 Bim 触发 NF1 相关恶性外周神经鞘瘤的细胞凋亡。
Cell Rep. 2014 Jan 16;6(1):81-92. doi: 10.1016/j.celrep.2013.12.001. Epub 2013 Dec 27.
2
Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.BRD4、EZH2和TOP2A在神经纤维瘤和恶性外周神经鞘膜瘤中的表达及抑制作用
PLoS One. 2017 Aug 15;12(8):e0183155. doi: 10.1371/journal.pone.0183155. eCollection 2017.
3
Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.克服恶性外周神经鞘瘤中的 BET 抑制剂耐药性。
Clin Cancer Res. 2019 Jun 1;25(11):3404-3416. doi: 10.1158/1078-0432.CCR-18-2437. Epub 2019 Feb 22.
4
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.双重mTORC1/2抑制在与神经纤维瘤病1型相关的丛状神经纤维瘤和恶性外周神经鞘膜瘤细胞中诱导抗增殖作用。
Oncotarget. 2016 Jun 14;7(24):35753-35767. doi: 10.18632/oncotarget.7099.
5
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.抑制 Eyes Absent Homolog 4 的表达可诱导恶性外周神经鞘瘤坏死。
Oncogene. 2010 Jan 21;29(3):368-79. doi: 10.1038/onc.2009.360. Epub 2009 Nov 9.
6
NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.NF1 缺失导致来源于神经纤维瘤病 1 相关恶性外周神经鞘瘤的雪旺细胞中 Bcl-xL 的上调。
Int J Oncol. 2013 Feb;42(2):657-66. doi: 10.3892/ijo.2012.1751. Epub 2012 Dec 24.
7
MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors.微小 RNA-204 对恶性外周神经鞘瘤的致癌作用具有关键调控作用。
Neuro Oncol. 2012 Aug;14(8):1007-17. doi: 10.1093/neuonc/nos124. Epub 2012 Jun 19.
8
The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.表观遗传调节剂 I-BET151 诱导人黑色素瘤细胞中 BIM 依赖性细胞凋亡和细胞周期停滞。
J Invest Dermatol. 2014 Nov;134(11):2795-2805. doi: 10.1038/jid.2014.243. Epub 2014 Jun 6.
9
The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.细胞视黄酸结合蛋白2促进恶性外周神经鞘瘤细胞的存活。
Am J Pathol. 2017 Jul;187(7):1623-1632. doi: 10.1016/j.ajpath.2017.02.021. Epub 2017 May 11.
10
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.CXCR4/CXCL12 介导 NF1 相关恶性外周神经鞘瘤的自分泌细胞周期进程。
Cell. 2013 Feb 28;152(5):1077-90. doi: 10.1016/j.cell.2013.01.053. Epub 2013 Feb 21.

引用本文的文献

1
Therapeutic Targeting of BET Proteins in Sarcoma.肉瘤中BET蛋白的治疗靶点
Mol Cancer Ther. 2025 Sep 2;24(9):1320-1330. doi: 10.1158/1535-7163.MCT-24-1027.
2
The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.CoREST复合物是恶性外周神经鞘瘤中的一个治疗靶点。
Sci Rep. 2025 Mar 24;15(1):10128. doi: 10.1038/s41598-025-94517-w.
3
Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.盘状结构域受体抑制剂DDR1-IN-1可诱导恶性外周神经鞘瘤发生自噬和坏死性细胞死亡。

本文引用的文献

1
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.泛素连接酶 FBXW7 通过调节 MYC 稳定性来调节白血病起始细胞的活性。
Cell. 2013 Jun 20;153(7):1552-66. doi: 10.1016/j.cell.2013.05.041.
2
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.正向遗传筛选致恶性外周神经鞘瘤形成,发现新基因和通路驱动肿瘤发生。
Nat Genet. 2013 Jul;45(7):756-66. doi: 10.1038/ng.2641. Epub 2013 May 19.
3
Selective inhibition of tumor oncogenes by disruption of super-enhancers.
Cell Death Discov. 2025 Mar 1;11(1):83. doi: 10.1038/s41420-025-02367-2.
4
Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.MEK、BET和CDK抑制剂三联组合显著减少小鼠模型中的人类恶性外周神经鞘瘤。
Clin Cancer Res. 2025 Mar 3;31(5):907-920. doi: 10.1158/1078-0432.CCR-24-2807.
5
Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors.NF-1 相关肿瘤的治疗策略:过去、现在和未来。
Curr Oncol Rep. 2024 Jun;26(6):706-713. doi: 10.1007/s11912-024-01527-4. Epub 2024 May 6.
6
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.胰腺神经内分泌肿瘤:信号通路与表观遗传调控
Int J Mol Sci. 2024 Jan 22;25(2):1331. doi: 10.3390/ijms25021331.
7
A worldwide bibliometric analysis of malignant peripheral nerve sheath tumors from 2000 to 2022.2000年至2022年恶性外周神经鞘瘤的全球文献计量分析
Front Oncol. 2023 Jan 27;13:1111985. doi: 10.3389/fonc.2023.1111985. eCollection 2023.
8
Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.验证含溴结构域和额外末端结构域蛋白作为2型神经纤维瘤病治疗靶点的有效性。
Neurooncol Adv. 2022 May 13;4(1):vdac072. doi: 10.1093/noajnl/vdac072. eCollection 2022 Jan-Dec.
9
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.癌症中 PRC2 失活突变通过增强病毒模拟增强了对 DNMT1 靶向治疗的细胞毒性反应。
Cancer Discov. 2022 Sep 2;12(9):2120-2139. doi: 10.1158/2159-8290.CD-21-1671.
10
Malignant peripheral nerve sheath tumor: models, biology, and translation.恶性外周神经鞘瘤:模型、生物学和转化。
Oncogene. 2022 Apr;41(17):2405-2421. doi: 10.1038/s41388-022-02290-1. Epub 2022 Apr 7.
通过破坏超级增强子选择性抑制肿瘤癌基因。
Cell. 2013 Apr 11;153(2):320-34. doi: 10.1016/j.cell.2013.03.036.
4
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.经典 Wnt/β-连环蛋白信号通路驱动人许旺细胞的转化、进展和肿瘤维持。
Cancer Discov. 2013 Jun;3(6):674-89. doi: 10.1158/2159-8290.CD-13-0081. Epub 2013 Mar 27.
5
PUMA and BIM are required for oncogene inactivation-induced apoptosis.PUMA 和 BIM 是癌基因失活诱导凋亡所必需的。
Sci Signal. 2013 Mar 26;6(268):ra20. doi: 10.1126/scisignal.2003483.
6
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.CXCR4/CXCL12 介导 NF1 相关恶性外周神经鞘瘤的自分泌细胞周期进程。
Cell. 2013 Feb 28;152(5):1077-90. doi: 10.1016/j.cell.2013.01.053. Epub 2013 Feb 21.
7
Inhibition of BET bromodomain targets genetically diverse glioblastoma.抑制 BET 溴结构域靶点可治疗遗传异质性脑胶质瘤。
Clin Cancer Res. 2013 Apr 1;19(7):1748-59. doi: 10.1158/1078-0432.CCR-12-3066. Epub 2013 Feb 12.
8
EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.EGFR-STAT3 信号通路促进恶性外周神经鞘瘤的形成。
Oncogene. 2014 Jan 9;33(2):173-80. doi: 10.1038/onc.2012.579. Epub 2013 Jan 14.
9
Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.磷酸化开关触发 Brd4 染色质结合和激活剂募集,实现基因特异性靶向。
Mol Cell. 2013 Mar 7;49(5):843-57. doi: 10.1016/j.molcel.2012.12.006. Epub 2013 Jan 11.
10
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models.联合 BCL-XL 和 MEK 抑制的合成致死相互作用促进 KRAS 突变型癌症模型中的肿瘤消退。
Cancer Cell. 2013 Jan 14;23(1):121-8. doi: 10.1016/j.ccr.2012.11.007. Epub 2012 Dec 13.